J&J says its single dose protects against breakthrough COVID-19 for up to 6 months

/
1 min read
FILE PHOTO: Vials labeled "COVID-19 Coronavirus Vaccine" and syringe are seen in front of displayed J&J logo in this illustration

-Johnson & Johnson said on Thursday that a real-world study showed its single shot COVID-19 vaccine protects against breakthrough infections and hospitalizations for up to six months.

The study, sponsored by the vaccine developer, was conducted between Jan. 1 and Sept. 7 last year, before the Omicron variant was discovered. It is also yet to be peer-reviewed.

J&J said protection against infection from its single dose vaccine starts to wane only from the fourth month compared to the second month in the case of two-dose vaccines from rivals Pfizer Inc and BioNTech’s as well as Moderna.

No waning of protection was found for ICU admissions for all the three vaccines, J&J said.

The company said the study was carried out by collecting claims and laboratory data covering 168 million people.

(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)

tagreuters.com2022binary_LYNXMPEI050VZ-BASEIMAGE


Breaking News
U.S. stocks end down slightly after early boost from Powell; oil falls